Tyra Biosciences Inc (TYRA) Actualités

Form 3 - Initial statement of beneficial ownership of securities

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer PR Newswire CARLSBAD, Calif., Sept. 10...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights PR Newswire CARLSBAD, Calif...

Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)

Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 23, 2024...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities